Emami Ltd
Emami Ltd Q4 FY25 Results & Concall Highlights: Revenue, Margins & Order Book
Q4 FY25 earnings call: what management guided on revenue, margins and order book.
The short version
Emami expects strong performance across the board in FY ‘26, with market shares and household penetration trending upwards. Emami Limited is optimistic about strong all-round growth in FY ‘26 driven by market share gains and household penetration improvements.
From Emami Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Emami expects strong performance across the board in FY ‘26, with market shares and household penetration trending upwards.
- Optimistic about growth in male grooming (Smart and Handsome), Kesh King, and The Man Company due to strategic actions and new leadership.
- Anticipates gradual consumption pickup supported by easing inflation, higher disposable income, government CAPEX, accommodative monetary policy, and potential rate cuts.
- Organized channels (modern trade, e-commerce, institutional sales) growing faster than overall domestic business, indicating further growth potential.
- International business showing promising rebound with growth in SAARC, Southeast Asia, CIS, and Africa regions.
- New product development (NPD) momentum to continue, with over 25 new products launched in FY ‘25 and plans for more in FY ‘26.
- Targeting strong double-digit growth in The Man Company and Brillare brands in FY ‘26.
- Price growth expected at around 2%-3% for FY ‘26.
Profitability & Margins
See what Emami Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The transcript does not explicitly mention any specific current or future capex or strategic investment amounts.
- However, management expressed optimism about growth driven by easing inflation, tax benefits, and accommodative monetary policy, which may support capital investment activities.
- They emphasized strategic actions for male grooming, Kesh King, and The Man Company focused on growth and profitability.
- International business and strategic investments are showing promising signs of rebound, indicating continued focus on expanding these areas.
- There is significant investment in building brand franchises for The Man Company and Brillare, targeting high double-digit growth.
- New product development (NPD), especially in healthcare and D2C segments like Zanducare, continues with over 25 new product launches in FY ‘25.
- Overall, investment efforts are focused on advertising (Rs. 690+ crore spent in FY ‘25) and brand building rather than specific capex projects.
Top-ranked in Personal Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Emami Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Emami Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹925 Cr, net profit ₹143 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Emami Ltd's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q2 FY26 earnings call →
- Q1 FY26 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
Others in Personal Products this season
- Procter & Gamble Hygiene and Health Care Ltd (Q4 FY25)
Feminine care category has substantial runway as penetration is under 50%, with market leadership maintained and growth driven by product upgrades and…
- Gillette India Ltd (Q4 FY25)
Gillette India delivered a 12% sales growth and 40% profit growth in the past year, reflecting strong execution of their Integrated Growth Strategy. Key…
- Colgate-Palmoliv (Q4 FY25)
The premium 30% urban segment remains resilient and continues to drive growth. Key concall takeaways from Colgate-Palmolive (India) Ltd's Q4 FY25 earnings call…
Frequently Asked Questions
What were Emami Ltd Q4 FY25 results?
Emami expects strong performance across the board in FY ‘26, with market shares and household penetration trending upwards. Emami Limited is optimistic about strong all-round growth in FY ‘26 driven by market share gains and household penetration improvements.
What is Emami Ltd share price analysis?
Emami Ltd currently shows a neutral. The stock trades at a P/E of 23.2 with a market cap of ₹17,563 Cr. Investors should review the full earnings analysis for detailed insights.
Is Emami Ltd planning capital expenditure?
The transcript does not explicitly mention any specific current or future capex or strategic investment amounts. - However, management expressed optimism about growth driven by easing inflation, tax benefits, and accommodative monetary policy, which may support capital investment activities. - They emphasized strategic actions for male grooming, Kesh King, and The Man Company focused on growth and profitability. - International business and strategic investments are showing promising signs of rebound, indicating continued focus on expanding these areas. - There is significant investment in building brand franchises for The Man Company and Brillare, targeting high double-digit growth. - New product development (NPD), especially in healthcare and D2C segments like Zanducare, continues with over 25 new product launches in FY ‘25. - Overall, investment efforts are focused on advertising (Rs.
Keep Emami Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.